8.9
Memória imunológica e outros aspectos do CRISPR
O sistema CRISPR-Cas atua como um mecanismo de defesa bacteriano contra elementos genéticos invasores, como vírus e plasmídeos, constituindo a base pa…
O sistema CRISPR-Cas protege as bactérias de elementos genéticos estranhos.
Em laboratórios, o sistema é programado usando Cas-9 para editar genes em plantas, animais e humanos.
Cas9, uma endonuclease de Streptococcus pyogenes, é entregue às células com um RNA-sgRNA guia sintético.
O sgRNA guia Cas9 para a sequência do Motivo Adjacente do Protoespaçador, permitindo que ele se ligue e corte o DNA no local alvo.
Para a inserção do gene, Cas9, guiado por um sgRNA, cliva o local, permitindo a recombinação homóloga para inserir o novo gene.
Para deleção de genes, dois sgRNAs direcionam Cas9 para cortar ambas as extremidades da região alvo.
O gene é excisado e o sistema de reparo une as extremidades cortadas.
O CRISPR-Cas9 foi projetado para inativar o HIV extirpando seu DNA das células infectadas. Sistemas projetados como o Csy4 têm como alvo o RNA livre do HIV, embora esses métodos ainda sejam experimentais.
Além de direcionar um único locus, o CRISPR-Cas9 pode editar vários genes simultaneamente, como remover várias cópias retrovirais.
View the full transcript and gain access to JoVE Core videos
Q1: How does Cas9 identify and cut DNA at the target site?
Cas9, an endonuclease from Streptococcus pyogenes, uses a synthetic guide RNA (sgRNA) to locate specific DNA sequences. The sgRNA directs Cas9 to the Protospacer Adjacent Motif (PAM) sequence, typically 5'-NGG-3', allowing Cas9 to bind and introduce a double-stranded break at the precise target location.
Q2: What is the difference between gene insertion and gene deletion using CRISPR-Cas9?
Gene insertion uses one sgRNA to guide Cas9 to cleave a site, then homologous recombination inserts new genetic material. Gene deletion employs two sgRNAs directing Cas9 to cut both ends of a target region, excising the DNA fragment, which the cell's repair system then rejoins through non-homologous end joining.
Q3: How can CRISPR-Cas9 be used to treat HIV infections?
CRISPR-Cas9 has been designed to inactivate HIV by excising integrated viral DNA from infected cells. Additionally, engineered systems like Csy4 target free HIV RNA to degrade it, though these antiviral strategies remain experimental and represent emerging therapeutic approaches for combating viral infections.
Q4: What is the original function of the CRISPR-Cas system in bacteria?
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids. Originally discovered in prokaryotes, the antiviral system of bacteria and archaea has been repurposed as a powerful genome-editing tool for laboratory applications across diverse organisms.
Q5: Can CRISPR-Cas9 edit multiple genes simultaneously?
Yes, CRISPR-Cas9 enables multiplexed genome editing, allowing simultaneous modification of multiple genes in a single organism. This capability is particularly advantageous in complex genetic studies and therapeutic applications, such as removing multiple retroviral copies from infected cells in one editing event.
Q6: What organisms can be edited using CRISPR-Cas9 technology?
CRISPR-Cas9 has been reprogrammed to modify the genomes of diverse organisms, including plants, animals, and humans. This versatility makes it a revolutionary tool for genetic engineering across a wide range of biological systems and research applications in both basic and applied science.
Q7: How does the synthetic guide RNA direct Cas9 to the correct DNA location?
The synthetic single guide RNA (sgRNA) contains a complementary sequence that guides Cas9 to a specific genomic locus adjacent to the Protospacer Adjacent Motif (PAM). This precise targeting ensures Cas9 binds and cuts only at the intended DNA location, enabling accurate and efficient genome editing with minimal off-target effects.